Pluristem Therapeutics Inc. (PSTI) stock price moved 20.40% away from 20-Days Simple Moving Average, 5.07% from 50-Days Simple Moving Average and separated -12.28% from 200 Days Simple Moving Average. Pluristem Therapeutics Inc. (PSTI) reported no change 0.00% in recent buying and selling session with closing price of $ 1.07. The stock’s traded 0.14 million shares in session while it holds an average volume of 0.29 million shares. The PSTI switched 62.02% away from its 52 week minimum and distanced -35.15% from its 52 week peak. The volatility change in the previous week has observed by 5.45% and experienced of 8.09% change in the last month.
The short ratio in the company’s stock is documented at 7.08 and the short float is around of 1.92%. Beta factor, which measures the riskiness of the security, was registered at 1.08. The Company kept a record of 105.48 million floated shares and 115.79 million shares outstanding. The average true range of the stock is observed at 0.07 and the relative strength index of the stock is recorded at 59.99.
Pluristem Therapeutics Inc. (PSTI) Stock Profitability Levels:
The company made Return on equity of -91.60% in last 12 months period. Return on assets ratio of the Company was -69.90%.
For the past 5 years, The Company’s EPS growth has been nearly 8.30%. Analyst established EPS growth expected to grow of 22.40% for this year and EPS growth for next year is likely to attain at 45.20%.
Looking about the past performance history, the company jumped 2.88% for the last five trades and expanded 12.64% in one month period. The stock deteriorated -9.32% during the past three month period and discounted -14.40% in half year. During the yearly overview it downgraded -30.07% and shown 35.77% year to date performance.